Senner Christopher J.
Quince Therapeutics, Inc. · Director
Senner Christopher J. is listed in filings as Director at Quince Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 19, 2026, including sale activity. Recent filings connect the profile to Quince Therapeutics, Inc. (QNCX) and Exelixis Inc (EXEL). The current snapshot covers public activity from Aug 9, 2024 to May 19, 2026. Reported amounts are shown as $66.3K to $65.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Last Price |
|---|---|---|---|---|
| $3M125k shares | SellAug 9, 2024 | $27.19 | $55.55 | |
| $1M29.3k shares | SellFeb 24, 2025 | $36.14 | $55.55 | |
| $5M100k shares | SellMay 16, 2025 | $46.00 | $55.55 | |
| $1M30.6k shares | SellFeb 17, 2026 | $43.67 | $55.55 | |
| $1M34.3k shares | SellFeb 13, 2026 | $43.00 | $55.55 |